Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Comparison of human abdominal subcutaneous versus omental preadipocyte differentiation in primary culture.

Shahparaki A., Grunder L., Sorisky A.

Laboratory Study with a reported sample of 18 on Type 2 Diabetes, published in Metabolism (2002) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Metabolism (2002)
Country
United States
Reported sample size
18
Source database
PubMed
PMID
12200769
DOI
10.1053/meta.2002.34037

Abstract (original English)

Excess intra-abdominal fat is associated with a higher risk for type 2 diabetes mellitus and cardiovascular disease, yet little is known about what influences regional adipose tissue accumulation. Adipocytes arise from specialized fibroblast-like preadipocytes within the adipose tissue stromal-vascular compartment. The aim of our study was to determine if there are variations in preadipocyte differentiation between abdominal subcutaneous (SC) and omental (OM) preadipocytes. Abdominal SC and OM preadipocytes were isolated from adipose tissue obtained from 18 subjects (7 men, 11 women), undergoing elective abdominal surgery, by collagenase treatment and filtration/centrifugation. Preadipocytes were placed in culture and then differentiated for 3 weeks in a serum-free medium containing insulin, dexamethasone, isobutylmethylxanthine, and carbaprostacyclin. The cells were then harvested for measurement of cytosolic glycerol phosphate dehydrogenase (GPDH), a marker of terminal differentiation. Data are expressed as a differentiation index (DI), which was the log of the SC/OM ratio of GPDH values for each patient (calculated as 0 for an equivalent SC v OM responses). The mean DI for the group (n = 18) was 0.04, with a 95% confidence interval (CI) of -0.11 to 0.20. The mean DI for men was 0.07 (95% CI, -0.06 to 0.19), and that for women was 0.03 (95% CI, -0.21 to 0.27). This indicates

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AbdomenAdipocytesCell DifferentiationCells, CulturedCytosolFemaleGlycerolphosphate DehydrogenaseHumansMaleOmentum

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research